These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 29226682

  • 1. First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
    Liang J, Sun Z, Zhang D, Jin Q, Cai L, Ma L, Liu W, Ni Y, Zhang J, Yin Z.
    Mol Pharm; 2018 Jan 02; 15(1):207-215. PubMed ID: 29226682
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
    Jin Q, Zhao J, Gao M, Feng Y, Liu W, Yin Z, Li T, Song S, Ni Y, Zhang J, Huang D, Zhang D.
    Mol Imaging Biol; 2018 Aug 02; 20(4):551-561. PubMed ID: 29305726
    [Abstract] [Full Text] [Related]

  • 4. Radiolabeled Rhein as Small-Molecule Necrosis Avid Agents for Imaging of Necrotic Myocardium.
    Luo Q, Jin Q, Su C, Zhang D, Jiang C, Fish AF, Feng Y, Ni Y, Zhang J, Yin Z.
    Anal Chem; 2017 Jan 17; 89(2):1260-1266. PubMed ID: 27981843
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
    Li J, Zhang J, Yang S, Jiang C, Zhang D, Jin Q, Wang Q, Wang C, Ni Y, Yin Z, Song S.
    Mol Pharm; 2016 Jan 04; 13(1):232-40. PubMed ID: 26568406
    [Abstract] [Full Text] [Related]

  • 7. Preclinical Evaluation of Radioiodinated Hoechst 33258 for Early Prediction of Tumor Response to Treatment of Vascular-Disrupting Agents.
    Zhang D, Gao M, Yao N, Jiang C, Liu W, Li T, Song S, Huang D, Yin Z, Qiu Y, Jin Q.
    Contrast Media Mol Imaging; 2018 Jan 04; 2018():5237950. PubMed ID: 29681781
    [Abstract] [Full Text] [Related]

  • 8. Exploring diagnostic potentials of radioiodinated sennidin A in rat model of reperfused myocardial infarction.
    Jiang C, Gao M, Li Y, Huang D, Yao N, Ji Y, Liu X, Zhang D, Wang X, Yin Z, Jing S, Ni Y, Zhang J.
    Int J Pharm; 2015 Nov 10; 495(1):31-40. PubMed ID: 26302863
    [Abstract] [Full Text] [Related]

  • 9. Experimental evaluation of radioiodinated sennoside B as a necrosis-avid tracer agent.
    Zhang D, Huang D, Ji Y, Jiang C, Li Y, Gao M, Yao N, Liu X, Shao H, Jing S, Ni Y, Yin Z, Zhang J.
    J Drug Target; 2015 Feb 10; 23(2):180-90. PubMed ID: 25330022
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
    Liu W, Zhang D, Feng Y, Li Y, Huang D, Jiang C, Gao M, Peng F, Wang X, Jing S, Jiang X, Ni Y, Zhang J.
    J Drug Target; 2015 May 10; 23(4):371-9. PubMed ID: 25572455
    [Abstract] [Full Text] [Related]

  • 13. Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.
    Wang Q, Yang S, Jiang C, Li J, Wang C, Chen L, Jin Q, Song S, Feng Y, Ni Y, Zhang J, Yin Z.
    Sci Rep; 2016 Feb 16; 6():21341. PubMed ID: 26878909
    [Abstract] [Full Text] [Related]

  • 14. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
    Liu X, Feng Y, Jiang C, Lou B, Li Y, Liu W, Yao N, Gao M, Ji Y, Wang Q, Huang D, Yin Z, Sun Z, Ni Y, Zhang J.
    J Drug Target; 2015 Jun 16; 23(5):417-26. PubMed ID: 25655506
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and Evaluation of Diindole-Based MRI Contrast Agent for In Vivo Visualization of Necrosis.
    Zhang L, Liu L, Zhang D, Jin Q, Gao M, Wu T, Feng Y, Ni Y, Yin Z, Zhang J.
    Mol Imaging Biol; 2020 Jun 16; 22(3):593-601. PubMed ID: 31332630
    [Abstract] [Full Text] [Related]

  • 16. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
    Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A.
    Bioconjug Chem; 2007 Jun 16; 18(6):1924-34. PubMed ID: 17929883
    [Abstract] [Full Text] [Related]

  • 17. Radioiodinated hypericin disulfonic acid sodium salts as a DNA-binding probe for early imaging of necrotic myocardium.
    Duan X, Yin Z, Jiang C, Jin Q, Zhang D, Sun Z, Ye W, Zhang J.
    Eur J Pharm Biopharm; 2017 Aug 16; 117():151-159. PubMed ID: 28414189
    [Abstract] [Full Text] [Related]

  • 18. Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model.
    Liu X, Jiang C, Zhang D, Gao M, Peng F, Huang D, Sun Z, Ni Y, Zhang J, Yin Z.
    Oncotarget; 2015 Sep 22; 6(28):26400-10. PubMed ID: 26305548
    [Abstract] [Full Text] [Related]

  • 19. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
    Ni Y, Huyghe D, Verbeke K, de Witte PA, Nuyts J, Mortelmans L, Chen F, Marchal G, Verbruggen AM, Bormans GM.
    Eur J Nucl Med Mol Imaging; 2006 May 22; 33(5):595-601. PubMed ID: 16450141
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.